The new and improved Fed. R. Evid. 702 has been in place since last December. During this session, we will examine how the toughened up rule has been faring, in addition to discussing states that are adopting similar amendments to state evidence rules. The good news is that favorable decisions have occurred in almost every circuit. The bad news is that other courts persist in quoting propositions that the notes to the amendments declared “incorrect.”

This is Part 2 of a six-part series. Part 1, 340B Program: Update on Current Developments is taking place on November 12, 2024, Part 3, New Rule 16.1 on MDLs is taking place on November 13, 2024, Part 4, PFAS Litigation in the MedTech Industry: Key Cases and Emerging Trends is taking place on November 13, 2024, Part 5, Product Liability in Europe: Understanding and Planning for the EU’s Recent Complainant-Friendly Shift is taking place on November 14, 2024, and Part 6, The New Frontier: AI in Product Liability Law is taking place on November 14, 2024.

Each of these programs are presumptively approved for 1.0 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas, and West Virginia. Applications for CLE credit will be filed in Delaware, Florida, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed. Please allow 4-6 weeks after the program to receive a certificate of attendance.